CCT251455 |
CCT251455 : Inhibitor of TTK
Probe Summary
Selectivity
Potency
In Vivo
Control Compounds
Chemical Information
References
Vendors
Download
Probe Summary
| Targets | Biochemical/Biophysical Potency | Cellular Potency |
|---|---|---|
| TTK |
|
|
Inhibitor
up to 1 uM
Selectivity
In Vitro Selectivity Assessment
Selectivity Assessment Description:
High selectivity versus kinases tested in a broad kinome profiling panel.
Potency Cellular
In Vitro
TTK
Mode of Action: Inhibitor
Structure-Activity-Relationship data available? Yes
DOI Reference: 10.1021/jm401395s
In Vivo Validations
Mouse
Dose: 5 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
4.2 h
Systemic clearance:
23.8 mL/min/kg
Fb :
99.93%
Bioavailability:
83%
Volume of Distribution at Steady-State:
2.3 L/Kg
DOI Reference: 10.1021/jm401395s
Rat
Dose: 5 mg/Kg
Route of delivery:
Intravenous, Oral
Plasma half life:
3.1 h
Systemic clearance:
7.04 mL/min/kg
Bioavailability:
32%
Volume of Distribution at Steady-State:
1.75 L/Kg
DOI Reference: 10.1021/jm401395s
Chemical Information
| Molecular Formula | C26H26ClN7O2 |
| SMILEs | Cn1cc(-c2cc3cnc(Nc4ccc(-c5cncn5C)cc4Cl)cc3n2C(=O)OC(C)(C)C)cn1 |
| InChI | InChI=1S/C26H26ClN7O2/c1-26(2,3)36-25(35)34-21(18-12-30-33(5)14-18)9-17-11-29-24(10-22(17)34)31-20-7-6-16(8-19(20)27)23-13-28-15-32(23)4/h6-15H,1-5H3,(H,29,31) |
| Molecular weight | 503.18 Da |
| AlogP | 6.0175 |
| HBond acceptors | 9 |
| HBond donors | 1 |
| Atoms | 62 |
References
Publications
Vendors
Note: This is not an exhaustive list and does not indicate endorsement by the portal.